Cargando…
Early Lifetime Substance Use and Development of Visual Impairment: Analysis of the National Survey on Drug Use and Health Data
PURPOSE: To investigate the association between early lifetime substance use on the development of severe visual acuity impairment or blindness on a national level. METHODS: National Survey of Drug Use and Health data was used to identify cases of substance use before 21* years of age, within the pa...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030542/ https://www.ncbi.nlm.nih.gov/pubmed/36968284 http://dx.doi.org/10.2147/OPTH.S401167 |
_version_ | 1784910399395594240 |
---|---|
author | Hussain, Zain S Khan, Asher Loya, Asad Shah, Kaushal Woreta, Fasika A Riaz, Kamran M |
author_facet | Hussain, Zain S Khan, Asher Loya, Asad Shah, Kaushal Woreta, Fasika A Riaz, Kamran M |
author_sort | Hussain, Zain S |
collection | PubMed |
description | PURPOSE: To investigate the association between early lifetime substance use on the development of severe visual acuity impairment or blindness on a national level. METHODS: National Survey of Drug Use and Health data was used to identify cases of substance use before 21* years of age, within the past year, and cases of self-reported blindness or visual impairment. Univariable and multivariable binary logistic regression with time-dependency was performed to evaluate odds of visual impairment influenced by 16 substances separated into three classes: prescription, non-prescription, and illicit drugs. Adjusted variables of interest included gender, marital status, race, level of education, total family income, poverty level, population density, and history of chronic disease. RESULTS: 55,824 total responses were analyzed with 2577 (4.6%) cases of self-reported blindness or significant visual impairment. All early-use substance categories, including prescription, non-prescription, and illegal substances, were significantly associated with self-reported VI (OR 2.068, CI 1.451–2.949, p<0.001; OR 1.352, CI 1.227–1.489, p<0.001); OR 1.211, CI 1.086–1.352, p<0.001), respectively). Non-prescription substances displayed parallel significances amongst all constituents (alcohol, cigarettes, inhalants, and marijuana) (OR=1.227, CI 1.12–1.344, p<0.001; OR 1.363, CI 1.243–1.495, p<0.001; OR 1.418, CI 1.134–1.774; OR 1.388, CI 1.27–1.518, p<0.001, respectively). Univariable and multivariable analysis revealed several significant demographical and clinical adjustors. CONCLUSION: Early lifetime use of all three classes of substances is associated with enhanced odds of subsequent visual impairment or blindness. Several readily available and commonly used substances have a greater risk. These findings may help clinicians and public health agencies in mitigation ventures including education, prevention, and rehabilitation efforts. |
format | Online Article Text |
id | pubmed-10030542 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-100305422023-03-23 Early Lifetime Substance Use and Development of Visual Impairment: Analysis of the National Survey on Drug Use and Health Data Hussain, Zain S Khan, Asher Loya, Asad Shah, Kaushal Woreta, Fasika A Riaz, Kamran M Clin Ophthalmol Original Research PURPOSE: To investigate the association between early lifetime substance use on the development of severe visual acuity impairment or blindness on a national level. METHODS: National Survey of Drug Use and Health data was used to identify cases of substance use before 21* years of age, within the past year, and cases of self-reported blindness or visual impairment. Univariable and multivariable binary logistic regression with time-dependency was performed to evaluate odds of visual impairment influenced by 16 substances separated into three classes: prescription, non-prescription, and illicit drugs. Adjusted variables of interest included gender, marital status, race, level of education, total family income, poverty level, population density, and history of chronic disease. RESULTS: 55,824 total responses were analyzed with 2577 (4.6%) cases of self-reported blindness or significant visual impairment. All early-use substance categories, including prescription, non-prescription, and illegal substances, were significantly associated with self-reported VI (OR 2.068, CI 1.451–2.949, p<0.001; OR 1.352, CI 1.227–1.489, p<0.001); OR 1.211, CI 1.086–1.352, p<0.001), respectively). Non-prescription substances displayed parallel significances amongst all constituents (alcohol, cigarettes, inhalants, and marijuana) (OR=1.227, CI 1.12–1.344, p<0.001; OR 1.363, CI 1.243–1.495, p<0.001; OR 1.418, CI 1.134–1.774; OR 1.388, CI 1.27–1.518, p<0.001, respectively). Univariable and multivariable analysis revealed several significant demographical and clinical adjustors. CONCLUSION: Early lifetime use of all three classes of substances is associated with enhanced odds of subsequent visual impairment or blindness. Several readily available and commonly used substances have a greater risk. These findings may help clinicians and public health agencies in mitigation ventures including education, prevention, and rehabilitation efforts. Dove 2023-03-14 /pmc/articles/PMC10030542/ /pubmed/36968284 http://dx.doi.org/10.2147/OPTH.S401167 Text en © 2023 Hussain et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Hussain, Zain S Khan, Asher Loya, Asad Shah, Kaushal Woreta, Fasika A Riaz, Kamran M Early Lifetime Substance Use and Development of Visual Impairment: Analysis of the National Survey on Drug Use and Health Data |
title | Early Lifetime Substance Use and Development of Visual Impairment: Analysis of the National Survey on Drug Use and Health Data |
title_full | Early Lifetime Substance Use and Development of Visual Impairment: Analysis of the National Survey on Drug Use and Health Data |
title_fullStr | Early Lifetime Substance Use and Development of Visual Impairment: Analysis of the National Survey on Drug Use and Health Data |
title_full_unstemmed | Early Lifetime Substance Use and Development of Visual Impairment: Analysis of the National Survey on Drug Use and Health Data |
title_short | Early Lifetime Substance Use and Development of Visual Impairment: Analysis of the National Survey on Drug Use and Health Data |
title_sort | early lifetime substance use and development of visual impairment: analysis of the national survey on drug use and health data |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030542/ https://www.ncbi.nlm.nih.gov/pubmed/36968284 http://dx.doi.org/10.2147/OPTH.S401167 |
work_keys_str_mv | AT hussainzains earlylifetimesubstanceuseanddevelopmentofvisualimpairmentanalysisofthenationalsurveyondruguseandhealthdata AT khanasher earlylifetimesubstanceuseanddevelopmentofvisualimpairmentanalysisofthenationalsurveyondruguseandhealthdata AT loyaasad earlylifetimesubstanceuseanddevelopmentofvisualimpairmentanalysisofthenationalsurveyondruguseandhealthdata AT shahkaushal earlylifetimesubstanceuseanddevelopmentofvisualimpairmentanalysisofthenationalsurveyondruguseandhealthdata AT woretafasikaa earlylifetimesubstanceuseanddevelopmentofvisualimpairmentanalysisofthenationalsurveyondruguseandhealthdata AT riazkamranm earlylifetimesubstanceuseanddevelopmentofvisualimpairmentanalysisofthenationalsurveyondruguseandhealthdata |